Literature DB >> 1660734

The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease.

I J Heuser1, T N Chase, M M Mouradian.   

Abstract

The functional integrity of the limbic-hypothalamic-pituitary-adrenal (LHPA) axis was studied in 10 patients with Huntington's disease (HD) and 10 age- and weight-matched control subjects by measuring basal ACTH and cortisol secretion, analyzing the subjects' ACTH and cortisol responses to corticotropin-releasing hormone (CRH) challenge, and by means of the dexamethasone-suppression test (DST). Basal cortisol and ACTH levels were significantly higher in patients with HD compared with controls. Following CRH administration, ACTH responses tended to be blunted in concert with normal cortisol levels. Two patients with HD and one control subject were DST nonsuppressors. Post-DST plasma dexamethasone levels were 57% lower among patients compared with the control group. Only in the HD group age was there an important variable in influencing spontaneous cortisol secretion as well as plasma dexamethasone levels during DST. These results suggest that patients with HD have an endogenous CRH overdrive, possibly due to a loss of (GABA) gamma-aminobutyric acid-containing neurons, and that age might have an effect on the outcome of LHPA axis function tests in patients only.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660734     DOI: 10.1016/0006-3223(91)90007-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  Increased irritability, anxiety, and immune reactivity in transgenic Huntington's disease monkeys.

Authors:  Jessica Raper; Steven Bosinger; Zachary Johnson; Gregory Tharp; Sean P Moran; Anthony W S Chan
Journal:  Brain Behav Immun       Date:  2016-07-07       Impact factor: 7.217

Review 2.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

3.  Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Authors:  Heike Runne; Alexandre Kuhn; Edward J Wild; Wirahpati Pratyaksha; Mark Kristiansen; Jeremy D Isaacs; Etienne Régulier; Mauro Delorenzi; Sarah J Tabrizi; Ruth Luthi-Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

Review 4.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 5.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

6.  Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Neurobiol Dis       Date:  2018-10-05       Impact factor: 5.996

7.  Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Brett D Dufour; Jodi L McBride
Journal:  Exp Neurol       Date:  2016-07-02       Impact factor: 5.330

8.  The relationship between cortisol and verbal memory in the early stages of Huntington's disease.

Authors:  Christopher A Shirbin; Phyllis Chua; Andrew Churchyard; Anthony J Hannan; Georgia Lowndes; Julie C Stout
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

9.  Islet beta-cell area and hormone expression are unaltered in Huntington's disease.

Authors:  Karl Bacos; Maria Björkqvist; Asa Petersén; Lena Luts; Marion L C Maat-Schieman; Raymund A C Roos; Frank Sundler; Patrik Brundin; Hindrik Mulder; Nils Wierup
Journal:  Histochem Cell Biol       Date:  2008-02-08       Impact factor: 4.304

10.  (3α,5α)3-hydroxypregnan-20-one (3α,5α-THP) regulation of hypothalamic and extrahypothalamic corticotropin releasing factor (CRF): Sexual dimorphism and brain region specificity in Sprague Dawley rats.

Authors:  Giorgia Boero; Ryan E Tyler; Caroline A Todd; Todd K O'Buckley; Irina Balan; Joyce Besheer; A Leslie Morrow
Journal:  Neuropharmacology       Date:  2021-01-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.